Compile Data Set for Download or QSAR
Report error Found 121 Enz. Inhib. hit(s) with all data for entry = 3425
TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283128(US9573930, Example 1 | US10023543, Example 1 | 4-(...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283129(US9573930, Example 2 | US10023543, Example 2 | 4-[...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283134(US9573930, Example 3 | US10023543, Example 3 | 4-[...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283199(US9573930, Example 4 | US10023543, Example 4 | 4-[...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283200(US9573930, Example 5 | US10023543, Example 5 | 4-[...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283215(US9573930, Example 6 | US10023543, Example 6 | 4-[...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283216(US9573930, Example 86 | US10023543, Example 86 | 4...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283217(US9573930, Example 8 | US10023543, Example 8 | 4-[...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283218(US9573930, Example 9 | US10023543, Example 9 | 4-[...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283220(US9573930, Example 10 | US10023543, Example 10 | 4...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283221(US9573930, Example 11 | US10023543, Example 11 | 2...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283222(US9573930, Example 12 | US10023543, Example 12 | 2...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283224(US9573930, Example 14 | US10023543, Example 14 | 4...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283225(US10023543, Example 15 | [2-(4-amino-piperidin-1-y...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283226(US9573930, Example 16 | US10023543, Example 16 | 2...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283228(US9573930, Example 18 | US10023543, Example 18 | 4...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283231(US9573930, Example 121 | 2-(4-amino-piperidin-1-yl...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283232(US10023543, Example 20 | 4-[2-(4-aminopiperidin-1-...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283233(US9573930, Example 21 | US10023543, Example 21 | 2...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283234(US9573930, Example 22 | US10023543, Example 22 | 4...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283235(US9573930, Example 23 | US10023543, Example 23 | 4...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283236(US9573930, Example 24 | US10023543, Example 24 | 4...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283237(US9573930, Example 25 | US10023543, Example 25 | 4...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283238(US9573930, Example 26 | US10023543, Example 26 | 4...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283239(US9573930, Example 27 | US10023543, Example 27 | 4...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283241(US9573930, Example 28 | US10023543, Example 28 | 4...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283242(US9573930, Example 29 | US10023543, Example 29 | 4...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283243(US9573930, Example 30 | US10023543, Example 30 | 4...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283244(US9573930, Example 31 | US10023543, Example 31 | 4...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM289889(4-[2-(4-amino-4-methyl-piperidin- 1-yl)-5-(3-fluor...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283247(US9573930, Example 33 | US10023543, Example 33 | 4...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283249(US9573930, Example 34 | US10023543, Example 34 | 4...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283250(US9573930, Example 35 | US10023543, Example 35 | 4...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283251(US9573930, Example 36 | US10023543, Example 36 | 4...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283252(US9573930, Example 37 | US10023543, Example 37 | 4...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283253(US9573930, Example 38 | US10023543, Example 38 | 4...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283255(US9573930, Example 40 | US10023543, Example 40 | {...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283256(US9573930, Example 41 | US10023543, Example 41 | 4...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283258(4-[2-(4-amino-piperidin-1-yl)-1- methyl-6-oxo-5-(1...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283260(US9573930, Example 44 | US10023543, Example 44 | 4...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283261(US9573930, Example 45 | US10023543, Example 45 | 4...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283263(US9573930, Example 46 | US10023543, Example 46 | 4...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283264(US9573930, Example 47 | US10023543, Example 47 | 2...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283265(US9573930, Example 48 | US10023543, Example 48 | 4...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283266(US9573930, Example 49 | US10023543, Example 49 | 4...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283267(US9573930, Example 50 | US10023543, Example 50 | 5...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283268(US9573930, Example 51 | US10023543, Example 51 | 2...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283269(US9573930, Example 52 | US10023543, Example 52 | 2...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283270(US9573930, Example 53 | US10023543, Example 53 | 2...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetLysine-specific histone demethylase 1A(Human)
Celgene

US Patent
LigandPNGBDBM283271(US9573930, Example 54 | US10023543, Example 54 | 2...)
Affinity DataIC50: 100nMAssay Description:This assay determines the ability of a test compound to inhibit LSD-1 demethylase activity. E. coli expressed full-length human LSD-1 (Accession numb...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

Displayed 1 to 50 (of 121 total ) | Next | Last >>
Jump to: